These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4995 related items for PubMed ID: 466655

  • 1. Biologic activity of MCNU: a new antitumor agent.
    Sekido S, Ninomiya K, Iwasaki M.
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
    Sekido S, Ninomiya K, Araki T, Ueno M, Kinbara M.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ, Wilson GL, Mossman BT, Angelino N, Kanter PM, Korytnyk W.
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K, Sekido S, Araki T.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
    [Abstract] [Full Text] [Related]

  • 8. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y, Arai Y, Taguchi H, Satoh H.
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [Abstract] [Full Text] [Related]

  • 9. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K, Fujimoto S, Ogawa M.
    Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
    [Abstract] [Full Text] [Related]

  • 10. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S, Ogawa M.
    Cancer Chemother Pharmacol; 1982 Oct; 9(3):134-9. PubMed ID: 6218931
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M, Sakurai Y.
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [Abstract] [Full Text] [Related]

  • 12. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T, McMenamin MG, Schein PS.
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [Abstract] [Full Text] [Related]

  • 13. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
    Kato T, Ota K.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
    [Abstract] [Full Text] [Related]

  • 14. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 15. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M, Okawa H, Ninomiya K, Sekine J, Nagamatsu Y.
    Gan; 1975 Jun 15; 66(3):347-8. PubMed ID: 1181236
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC, Trader MW, Dykes DJ, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Dec 15; 62(12):2085-93. PubMed ID: 751716
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S, Ogawa M, Hoshino A.
    Gan; 1980 Feb 15; 71(1):60-72. PubMed ID: 6929770
    [Abstract] [Full Text] [Related]

  • 18. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM.
    Cancer Res; 1983 Jun 15; 43(6):2880-3. PubMed ID: 6573953
    [Abstract] [Full Text] [Related]

  • 19. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I, Kobayashi T, Shirakawa S, Ikeda Y, Kobayashi M, Yamagata K, Ohta K, Ohno R, Yamada H, Yamada K.
    Gan To Kagaku Ryoho; 1985 Mar 15; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA, Fox P, Schein PS.
    Cancer Res; 1978 Jan 15; 38(1):65-8. PubMed ID: 145314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 250.